December 2015
Cummings Issues Statement on Arrest and Resignation of Martin Shkreli
Washington, DC (Dec. 18, 2015)—Today, Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform, issued the following statement in response to the arrest and resignation of former hedge fund manager and Turing CEO Martin Shkreli:
Skyrocketing Generic Drug Prices Cost Taxpayers $1.4 Billion, New Report Finds
WASHINGTON, Dec. 17 – Skyrocketing generic drug prices cost taxpayers an additional $1.4 billion over the last decade according to a new report from the Department of Health and Human Services' inspector general, undertaken at the request of Sen. Bernie Sanders (I-Vt.) and Rep. Elijah Cummings (D-Md.), ranking member of the House Committee on Oversight and Government Reform.
Cummings Criticizes CFTC for Failing to Impose Strong Regulations on Wall Street
Finalized Rule Continues Allowing Big Banks to
Fund Risky Bets With Taxpayer-Backed Dollars
Washington, DC (Dec. 16, 2015)—In advance of an upcoming hearing before the House Committee on Oversight and Government Reform, Ranking Member Elijah E. Cummings sent a letter to J. Michael Pearson, CEO of Valeant Pharmaceuticals, demanding documents and interviews that the company has so far refused to provide voluntarily.
Cummings, Cardin Introduce Legislation to Protect State and Local Witnesses from Violence and Intimidation
Washington, D.C. (December 9, 2015) — Today, Congressman Elijah E. Cummings and Senator Ben Cardin (both D-MD) introduced the Witness Security and Protection Grant Program Act of 2015, legislation that directs the U.S.